Ad
ORMP - Oramed Pharmaceuticals Stock Trading
About | Oramed Pharmaceuticals Inc. (NASDAQ:ORMP)
Oramed Pharmaceuticals OTC:ORMP.OB is developing proprietary technology for the oral delivery of drugs presently administered by way of injection. Through its patented flagship product, an oral insulin capsule currently in Phase trials, the Company is seeking to revolutionize the treatment of diabetes.
Quote | Oramed Pharmaceuticals Inc. (NASDAQ:ORMP)
| Last: | $3.96 |
|---|---|
| Change Percent: | -3.83% |
| Open: | $3.8 |
| Close: | $3.96 |
| High: | $4.05 |
| Low: | $3.65 |
| Volume: | 633,520 |
| Last Trade Date Time: | 05/26/2023 03:00:00 am |
News | Oramed Pharmaceuticals Inc. (NASDAQ:ORMP)
-
Oramed to Present at Novel Therapies for Type 2 Diabetes & Obesity Summit Oramed to Present at Novel Therapies for Type 2 Diabetes & Obesity Summit PR Newswire NEW YORK , May 18, 2023 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: O...
-
2023-05-16 21:04:48 ET Summary On May 15, Oramed announced that their partner in China had completed a positive phase 3 oral insulin trial in China and had submitted an application to the Chinese regulator. In the same PR, Oramed announced their post-hoc analysis of their failed U...
Message Board Posts | Oramed Pharmaceuticals Inc. (NASDAQ:ORMP)
| Subject | By | Source | When |
|---|---|---|---|
| I agree - I will be happy if | Amatuer17 | investorshub | 05/15/2023 2:49:52 PM |
| I am completely out of this stock | midastouch017 | investorshub | 05/15/2023 2:42:47 PM |
| That is good news for Oramed - not | Amatuer17 | investorshub | 05/15/2023 2:38:29 PM |
| 3.8200+0.9900 (+34.9823%) | midastouch017 | investorshub | 05/15/2023 1:51:05 PM |
| Oramed Announces that its Chinese Partner, HTIT, has | midastouch017 | investorshub | 05/15/2023 1:22:47 PM |
Oramed Pharmaceuticals Inc. Company Name:
ORMP Stock Symbol:
NASDAQ Market:
Oramed Pharmaceuticals Inc. Website:
News, Short Squeeze, Breakout and More Instantly...
Ad
